GLP-1 Medicines for Weight Loss: What Patients Should Know Before Starting Treatment | Dr. Moxit Shah

Dr. Moxit Shah, DM Endocrinology | Endocrinologist in Ahmedabad

GLP-1 medicines have changed the way doctors approach medical weight management. For appropriately selected patients, medicines such as semaglutide and tirzepatide can reduce appetite, increase fullness and support clinically meaningful weight loss. But these medicines are not simply “weight-loss injections”: they are prescription treatments that need appropriate patient selection, gradual dose escalation and regular follow-up.

What Are GLP-1 Medicines?

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in appetite regulation, insulin secretion, glucagon regulation and gastric emptying. GLP-1 receptor agonists mimic some of these effects. Tirzepatide acts on both GIP and GLP-1 receptors and is therefore a dual incretin medicine.

How Do GLP-1 Medicines Help With Weight Loss?

• Lower appetite: Hunger signals can become less intense.
• Increase satiety: Smaller meals may feel more satisfying.
• Slow gastric emptying: This can contribute to a longer feeling of fullness.
• Improve glucose regulation: They can improve blood glucose control in appropriate people with type 2 diabetes.
• Support sustained dietary change: Reduced appetite can make an appropriate calorie deficit easier to maintain.

Who May Benefit From GLP-1-Based Weight Management?

Weight-loss medication is generally considered when excess weight is associated with meaningful health risk and lifestyle measures alone have not achieved adequate results. The exact eligibility depends on the medicine, indication and individual clinical circumstances.

For example, the current U.S. prescribing information for Wegovy (semaglutide) includes long-term weight reduction and maintenance for adults with obesity and for adults with overweight in the presence of at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity. urlCurrent FDA Wegovy prescribing informationhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf

An endocrinology assessment should consider weight history, BMI, waist-related risk, diabetes or prediabetes, blood pressure, lipids, sleep apnea, fatty liver disease, medications and other medical factors.

Semaglutide vs Tirzepatide

Semaglutide is a GLP-1 receptor agonist, while tirzepatide activates both GIP and GLP-1 receptors. Clinical trials have demonstrated substantial average weight loss with both medicines. In SURMOUNT-1, tirzepatide produced substantial weight reduction over 72 weeks, with gastrointestinal adverse effects being the most common and occurring particularly during dose escalation. urlNEJM SURMOUNT-1 trialhttps://www.nejm.org/doi/10.1056/NEJMoa2206038

For a detailed comparison, read Semaglutide vs Tirzepatide for Weight Loss.

What Should You Expect After Starting Treatment?

Most treatment plans begin with a lower dose and gradually increase it according to the specific medicine’s prescribing information. The goal is not to reach the highest dose as quickly as possible. Gradual escalation can improve tolerability and allows treatment to be individualized according to response and adverse effects.

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Bloating
• Abdominal discomfort or indigestion
• Reduced appetite

In clinical trials, gastrointestinal symptoms were among the most frequently reported adverse effects and often occurred during dose escalation. urlNEJM semaglutide STEP 1 trialhttps://www.nejm.org/doi/full/10.1056/NEJMoa2032183

Eating smaller meals, eating slowly, avoiding very large or high-fat meals when symptoms are active and maintaining adequate hydration may improve tolerability. Persistent vomiting, dehydration, severe abdominal pain or other concerning symptoms require medical assessment.

Read more: GLP-1 Side Effects: What to Expect and How to Manage Them.

Nutrition and Exercise Still Matter

Medication should be part of a broader weight-management strategy. Adequate protein, vegetables, fibre-rich foods, hydration and appropriate portions remain important. Resistance exercise is particularly useful during weight loss because maintaining muscle mass is an important part of healthy weight reduction.

For practical nutrition guidance, see What to Eat While Taking GLP-1 Medicines.

What About Unapproved or Compounded GLP-1 Products?

Patients should be cautious when purchasing GLP-1 medicines online or using products of uncertain origin. The FDA has reported concerns regarding unapproved GLP-1 products and dosing errors associated with some compounded semaglutide and tirzepatide products. Patients should obtain prescription medicines through appropriate medical and pharmacy channels and discuss any compounded treatment with their doctor. urlFDA: Concerns with unapproved GLP-1 drugshttps://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Important Safety Considerations

GLP-1-based medicines are not suitable for everyone. The treating doctor should review medical history, other medicines, gastrointestinal conditions, pregnancy plans and medicine-specific contraindications before treatment. For example, current U.S. prescribing information for Wegovy lists a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 as a contraindication. urlFDA Wegovy prescribing informationhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf

What Happens If You Stop a GLP-1 Medicine?

Weight management is often a long-term process. Some people regain weight after stopping effective pharmacological treatment because appetite and the biological drive toward weight regain may return. The decision to continue, adjust or stop treatment should therefore be discussed with your treating physician rather than stopping medication independently.

Read more: What Happens When You Stop GLP-1 Medicines?

Frequently Asked Questions

Do GLP-1 medicines directly burn fat?

The major effect is not direct fat burning. By reducing appetite and food intake, these medicines can help create a sustained energy deficit that leads to weight loss.

Can people without diabetes use GLP-1 medicines?

Yes, certain medicines in this class are approved for chronic weight management in eligible people without diabetes. The exact indication depends on the medicine and applicable regulatory approval.

Should I increase the dose faster if my weight loss is slow?

No. Dose escalation should follow the medicine’s prescribing information and your clinician’s plan. Faster escalation can increase adverse effects and does not guarantee better long-term results.

Medical Weight Loss in Ahmedabad

Dr. Moxit Shah, DM Endocrinology provides specialist evaluation and management for Diabetes, Thyroid disorders and Medical Weight Loss at Vishuddha Endocrine Clinic in Ahmedabad.

Vishuddha Endocrine Clinic
Elite Magnum, Bhuyangdev Cross Road, Memnagar/Ghatlodia, Ahmedabad
Appointments: +91 99799 92797

This article is for educational purposes and does not replace an individual medical consultation. GLP-1 medicines are prescription treatments and should be used only under appropriate medical supervision.